This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Cardiovascular Diseases, Heart Failure or Heart Failure, Diastolic
and you are
between 45 and 75
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Current therapies for heart failure (HF) bring together strategies to improve quality of life and exercise tolerance, as well as to reduce morbidity and mortality. Some HF patients present changes in the musculoskeletal system and inspiratory muscle weakness, which may be restored by inspiratory muscle training, thus increasing respiratory muscle strength and endurance, maximum oxygen consumption (VO2), functional capacity, respiratory responses to exercise, and quality of life. Yoga therapies have been shown to improve quality of life, inflammatory markers, and VO2 peak in HF patients, mostly with reduced ejection fraction (HFrEF). However, the effect of different yoga breathing techniques in patients with HF with preserved ejection fraction (HFpEF) has yet to be assessed.

Provided treatments

  • Other: Yôga
  • Other: Breathing technique
  • Other: Control group
Tris trial is registered with FDA with number: NCT03028168. The sponsor of the trial is Hospital de Clinicas de Porto Alegre and it is looking for 32 volunteers for the current phase.
Official trial title:
Yôga and Breathing Techniques Training in Patients With Heart Failure and Preserved Ejection Fraction: Study Protocol for a Randomized Clinical Trial